(Q48485909)

11 February 2018

title

Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2. (English)

1 reference

11 February 2018

author name string

H B Niznik

1 reference

11 February 2018

D E Grigoriadis

1 reference

11 February 2018

I Pri-Bar

1 reference

11 February 2018

O Buchman

1 reference

11 February 2018

P Seeman

1 reference

11 February 2018

publication date

1 June 1985

1 reference

11 February 2018

Naunyn-Schmiedeberg's Archives of Pharmacology

published in

1 reference

11 February 2018

volume

329

1 reference

11 February 2018

issue

1 reference

11 February 2018

page(s)

333-343

1 reference

11 February 2018

A comparison of in vitro and in vivo dopamine receptor antagonism produced by substituted benzamide drugs

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00496365

Investigation on central dopaminergic receptors (D-2) using the antagonistic properties of new benzamides

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00496365

A comparison of some of the properties of the [3H]-sulpiride binding site in soluble and native membrane preparations of dog striatum

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00496365

Pharmacological studies on a new benzamide derivative, YM-09151-2, with potential neuroleptic properties

21 January 2018

1 reference

12 December 2020

Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions

1 reference

12 December 2020

Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes

1 reference

12 December 2020

Binding of [3H]sulpiride to purified rat striatal synaptic membranes

1 reference

12 December 2020

Potent lipophilic substituted benzamide drugs are not selective D-1 dopamine receptor antagonists in the rat

1 reference

12 December 2020

Substituted benzamides as cerebral dopamine antagonists in rodents

1 reference

12 December 2020

The effect of guanosine nucleotides of [3H]sulpiride binding to rat striatal membranes

1 reference

12 December 2020

Multiple receptors for dopamine

1 reference

12 December 2020

3HRo 22-1319 (piquindone) binds to the D2 dopaminergic receptor subtype in a sodium-dependent manner

1 reference

12 December 2020

Characteristics of [3H]sultopride binding to rat brain

1 reference

12 December 2020

3H-Dopamine binding sites differ in rat striatum and pituitary

1 reference

12 December 2020

Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.

1 reference

12 December 2020

Selective blockade of dopamine D-1 receptors by SCH 23390 discloses striatal dopamine D-2 receptors mediating the inhibition of adenylate cyclase in rats

1 reference

12 December 2020

Selective binding of YM-09151-2, a new potent neuroleptic, to D2-dopaminergic receptors

1 reference

12 December 2020

[3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role.

1 reference

12 December 2020

Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding

1 reference

12 December 2020

Dopamine receptor parameters detected by [3H]spiperone depend on tissue concentration: analysis and examples

1 reference

12 December 2020

Substituted benzamide drugs as selective neuroleptic agents

1 reference

12 December 2020

Stereoselective actions of substituted benzamide drugs on cerebral dopamine mechanisms

1 reference

12 December 2020

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

1 reference

12 December 2020

Neuroleptic properties of cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-methylaminobenzamide (YM-09151-2) with selective antidopaminergic activity

1 reference

12 December 2020

SCH 23390—The first selective dopamine D-1 antagonist

1 reference

12 December 2020

Cation regulation differentiates specific binding of [3 H]sulpiride and [3 H]spiperone to rat striatal preparations

1 reference

12 December 2020

Cation specificity of 3H-sulpiride binding involves alteration in the number of striatal binding sites

1 reference

12 December 2020

Agonist high- and low-affinity states of the D2-dopamine receptor in calf brain. Partial conversion by guanine nucleotide

1 reference

12 December 2020

Sodium-dependent interaction of benzamides with dopamine receptors

1 reference

12 December 2020

Influence of sodium and sulphydryl groups on [3H]sulpiride binding sites in rat striatal membranes

1 reference

12 December 2020

Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum

1 reference

12 December 2020

Synthesis and neuroleptic activity of benzamides. Cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide and related compounds.

1 reference

12 December 2020

YM-09151-2: A potent antagonist for a peripheral D2-dopamine receptor

1 reference

12 December 2020

Effect of guanine nucleotides on striatal dopamine receptors

1 reference

12 December 2020

Effects of neuroleptics on 3H-haloperidol and 3H-CIS (Z)-flupenthixol binding and on adenylate cyclase activity in vitro

1 reference

12 December 2020

Specific binding of [3H]sulpiride to rat striatal preparations

1 reference

12 December 2020

Brain dopamine receptors

1 reference

12 December 2020

SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems

1 reference

12 December 2020

Complete conversion of brain D2 dopamine receptors from the high- to the low-affinity state for dopamine agonists, using sodium ions and guanine nucleotide

1 reference

12 December 2020

Selection of dopamine antagonists discriminating various behavioral responses and radioligand binding sites

1 reference

12 December 2020

Effect of a novel benzamide, YM-09151-2, on rat serum prolactin levels

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00496365

1 reference

11 February 2018

1 reference

11 February 2018